Navigation Links
CareFusion to Provide Pyxis® Point-of-Care Products to Veterans Affairs Hospitals Nationwide
Date:12/6/2010

SAN DIEGO, Dec. 6, 2010 /PRNewswire-FirstCall/ -- CareFusion (NYSE: CFN), a leading, global medical device company, today announced the award of the Pyxis® point-of-care verification suite of products across 153 U.S. Department of Veteran Affairs (VA) medical centers and 17 outpatient centers.

(Logo:  http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO)

The VA is already one of the largest users of barcode medication administration technology and this agreement expands and upgrades their existing technology. The contract is one of the largest in the history of CareFusion's Pyxis point-of-care verification product line.

CareFusion will provide the VA with a suite of positive patient identification products to help reduce the potential for errors during specimen collection and blood transfusion. The Pyxis® Specimen Collection Verification system focuses on ensuring clinicians correctly label and collect a patient's lab specimens and the Pyxis® Transfusion Verification system ensures the appropriate blood product is transfused to the right patient at the right time.

The agreement also extends existing bar code technology for medication administration using a portable wireless platform, allowing clinicians to verify medication orders and view safety alerts and allergy warnings on a handheld device at the patient's bedside.

"By expanding the use of bar coding technology, the VA will continue to help America's veterans receive the best medical care possible," said Tom Leonard, president of Dispensing Technologies at CareFusion. "CareFusion is a leader in developing innovative solutions to enhance patient care and safety."

CareFusion plans to expand its specimen verification product line to include both clinical and anatomical pathology, which will help decrease patient/specimen mismatch and specimen mislabeling at the point of collection, as well as help with diagnosis of disease based on examination of organs, tissues and whole bodies. This product is currently under development and not commercially available.

The contract with the VA is through an agreement with MicroTech, a leading technology systems integrator.

About CareFusion Corporation

CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® IV pumps, Pyxis® automated dispensing and patient identification systems, AirLife™, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for infection surveillance, V. Mueller® and Snowden-Pencer® surgical instruments and NeuroCare diagnostic products. CareFusion employs more than 15,000 people across its global operations. More information may be found at www.carefusion.com.


'/>"/>
SOURCE CareFusion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Launches Next-Generation Clinical Pulmonary and Cardiopulmonary Diagnostics Software
2. CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance
3. CareFusion Selects Palomar Pomerado Health as Development Partner for Patient Safety Technologies
4. CareFusion Will Host an Earnings Conference Call on Nov. 2 to Discuss the Results for the First Quarter Fiscal 2011
5. CareFusion Recall of Alaris PC Units Model 8015 Classified as Class I Recall
6. CareFusion Expands Skin Antisepsis Portfolio
7. CareFusion and Blue Cross and Blue Shield of Illinois Create Illinois Hospital Quality Initiative to Help Eliminate Health Care-Associated Infections
8. CareFusion Announces National Launch of Spinal Fracture Device
9. CareFusion Will Host an Earnings Conference Call on Aug. 10 to Discuss the Results for the Fourth Quarter and Fiscal 2010
10. CareFusion Launches First Automatic Oxygen Controller to Improve Care for Newborns Needing Mechanical Ventilation
11. CareFusion Completes Medegen Acquisition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... innovative, personalized cell-based treatment for a high-risk form of the most common ... Hospital of Philadelphia today reported new results using ... The physician-scientists presented findings at the annual meeting of the American ... Continue Reading ... ...
(Date:12/2/2016)... , Dec 2, 2016 Research and Markets ... newsletter to their offering. ... , , R&D Drug ... Publishing,s proprietary R&D Drug Pipeline Database provides 24/7 online access to ... on the market and on investigational drug candidates in research & ...
(Date:12/2/2016)... Columbia , December 2, 2016 - bioLytical lanza el ... nuevas directrices de la OMS     Continue Reading ... ... , , ... enfermedades infecciosas, ha anunciado hoy que está expandiendo el lanzamiento de su INSTI ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and ... who do not do their research and undergo cosmetic dermatology treatments from unqualified practitioners ... of a renaissance and every other month a new treatment or device is launched, ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... called the CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial ... healthcare settings. , Over the last 60 years, studies have shown that ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
Breaking Medicine News(10 mins):